• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Inspira Technologies and Genius Group Interviews to Air on Bloomberg TV on the RedChip Money Report(R)

    5/5/23 9:00:00 AM ET
    $GNS
    $IINN
    Services-Misc. Amusement & Recreation
    Consumer Discretionary
    Medical/Dental Instruments
    Health Care
    Get the next $GNS alert in real time by email

    ORLANDO, FL / ACCESSWIRE / May 5, 2023 / RedChip Companies will air new interviews with Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN, IINNW))) and Genius Group Limited (NYSE:GNS) on The RedChip Money Report® on Bloomberg TV, this Saturday, May 6, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.

    Access the interviews in their entirety at:

    Inspira Technologies: https://www.redchip.com/assets/iinn_interview_access

    Genius Group: https://www.geniusuinfo.com/interview_access

    About The RedChip Money Report®

    The RedChip Money Report® is produced by RedChip Companies Inc., an international Investor Relations and media firm with 30 years' experience focused on Discovering Tomorrow's Blue Chips Today™. "The RedChip Money Report®" delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies.

    About Inspira Technologies

    Inspira Technologies is an innovative medical technology company in the respiratory treatment arena. The Company has developed a breakthrough Augmented Respiration Technology (INSPIRA ART), designed to rebalance patient oxygen saturation levels. This technology potentially allows patients to remain awake during treatment while reducing the need for highly invasive, risky, and costly mechanical ventilation systems that require intubation and medically induced coma. The Company's products have not yet been tested or used in humans and has not been approved by any regulatory entity.

    For more information, please visit our corporate website: https://inspira-technologies.com.

    About Genius Group

    Genius Group is a leading entrepreneur Edtech and education group, with a mission to disrupt the current education model with a student-centered, life-long learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in today's market. The group has a group user base of 4.3 million students and users in 200 countries, ranging from ages 0 to 100.

    For more information, please visit https://www.geniusgroup.net/.

    About RedChip Companies

    RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 30 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, the RedChip Money Report is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, "The RedChip Money Report," which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more.

    To learn more about RedChip's products and services, please visit:

    https://www.redchip.com/corporate/investor_relations

    "Discovering Tomorrow's Blue Chips Today"™

    Contact:

    Dave Gentry
    RedChip Companies Inc.
    1-800-RED-CHIP (733-2447)
    Or 407-491-4498
    [email protected]

    SOURCE: RedChip



    View source version on accesswire.com:
    https://www.accesswire.com/753126/Inspira-Technologies-and-Genius-Group-Interviews-to-Air-on-Bloomberg-TV-on-the-RedChip-Money-ReportR

    Get the next $GNS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GNS
    $IINN

    CompanyDatePrice TargetRatingAnalyst
    Inspira Technologies Oxy B.H.N. Ltd.
    $IINN
    11/1/2021$9.00 → $10.00Buy
    Aegis Capital
    Inspira Technologies Oxy B.H.N. Ltd.
    $IINN
    8/26/2021$9.00Buy
    Aegis Capital
    More analyst ratings

    $GNS
    $IINN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients

      RA'ANANA, Israel, May 07, 2025 (GLOBE NEWSWIRE) -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced that the INSPIRA™ ART100 has been approved by Israel's largest healthcare provider to undergo a clinical validation by leading physicians who intend to use the innovative life-support and diagnostic device during organ transplant procedures.  As part of this advancement, Inspira will deploy the U.S. Food and Drug Administration ("FDA") approved INSPIRA ART100 system at one of Israel's renowned medical centers affiliated with the largest health care provider. A team of pioneeri

      5/7/25 8:45:00 AM ET
      $IINN
      Medical/Dental Instruments
      Health Care
    • Genius Group Announces 2024 Financial Results, 303% NAV Growth

      Increase in Net Asset Value (NAV) to $79.4 million from $19.7 million in 2023. SINGAPORE, April 30, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE:GNS) ("Genius Group" or the "Company"), a leading AI-powered, Bitcoin-first education group, announced today its financial results for the year ended December 31, 2024. Business Highlights for Fiscal 2024 As a result of the restructured financials due to the failed asset purchase agreement currently the subject of arbitration and the RICO lawsuit filed by the Company, 2024 audited revenue of $7.9 million compared to $23.1 million in 2023.5.8 million students and users compared to 5.5 million in 2023.Reduction in cost of revenue to $5.3 m

      4/30/25 8:15:00 AM ET
      $GNS
      Services-Misc. Amusement & Recreation
      Consumer Discretionary
    • Genius Group to Release Full Year 2024 Results and Host Investor Webcast on April 30, 2025

      SINGAPORE, April 25, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE:GNS) ("Genius Group" or the "Company"), a leading AI-powered, Bitcoin-first education group, will announce full year 2024 financial results on Wednesday, April 30, 2025, prior to market open. Management will host a live webcast to discuss the results at 8:00 AM Eastern Time / 8:00 PM Singapore Time on Wednesday, April 30, 2025. Management will also provide updates on its AI-Powered Genius Curriculum, Genius City model, Bitcoin Treasury strategy, current legal cases and guidance for 2025. The webcast, along with supplemental information, can be accessed on the investor relations section of the Genius Group website. A

      4/25/25 8:00:00 AM ET
      $GNS
      Services-Misc. Amusement & Recreation
      Consumer Discretionary

    $GNS
    $IINN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Genius Group Limited

      SC 13G - Genius Group Ltd (0001847806) (Subject)

      11/14/24 5:32:28 PM ET
      $GNS
      Services-Misc. Amusement & Recreation
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by Inspira Technologies Oxy B.H.N. Ltd.

      SC 13G/A - Inspira Technologies OXY B.H.N. Ltd (0001837493) (Subject)

      11/14/24 4:08:42 PM ET
      $IINN
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by Genius Group Limited

      SC 13G - Genius Group Ltd (0001847806) (Subject)

      2/20/24 5:11:20 PM ET
      $GNS
      Services-Misc. Amusement & Recreation
      Consumer Discretionary

    $GNS
    $IINN
    Leadership Updates

    Live Leadership Updates

    See more
    • PESG Report: Inspira Technologies Strengthens its AI-Powered Blood Sensor with new Capabilities, Intends to Share Clinical Findings Soon

      Inspira Technologies* advancement of its AI-powered blood monitoring technology comes amid robust growth in medical technology M&A, with Q3 2024 seeing 275 deals worth $34 billion - a 35% increase year-over-year. The integration of this new oxygenation indicator strengthens the Company's position in both the $2.5 billion blood gas analysis market and, through the FDA-cleared INSPIRA ART100 system, the $19 billion mechanical ventilation market. With clinical evaluations of the HYLA blood sensor underway at Sheba Medical Center and preliminary results reportedly expected in the near future, the Company continues to execute its strategy of combining AI-enhanced monitoring capabilities with inn

      2/6/25 8:27:00 AM ET
      $IINN
      Medical/Dental Instruments
      Health Care
    • Inspira™ Announces the Appointment of Tal Parnes as the New Chairman of the Board, Bringing Vast Experience in the Medical Technology and Pharmaceutical Sectors

      RA'ANANA, Israel, Jan. 21, 2025 /PRNewswire/ -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) (Nasdaq: IINNW) ("Inspira" or the "Company"), a leader in life-support technology innovation, has announced the appointment of Mr. Tal Parnes as the new chairman of the board of directors, effective February 1, 2025.     Mr. Parnes brings a wealth of experience and expertise to his new role at Inspira. With a distinguished career spanning over three decades in the technology sector, with a special focus in the medical technology and pharmaceutical industries, Mr. Parnes has consistently demonstrated exceptional leadership and strategic vision. As a serial entrepreneur, Parnes has demonstrated

      1/21/25 8:30:00 AM ET
      $IINN
      Medical/Dental Instruments
      Health Care
    • Genius Group Restructures Board with Four New Appointees

      SINGAPORE, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE:GNS) ("Genius Group" or the "Company"), a leading AI-powered education and acceleration group, today announced changes to its Board and Management team commensurate with its international growth plans. The Company's Board of Directors has appointed Eduardo Huerta-Mercado Herrera, Ian Putter, Thomas Power and Gary Pattison to the Board, bringing with them extensive experience at Board and Senior Management levels in high-growth, international public companies and higher education institutions. Eduardo Huerta-Mercado Herrera is a seasoned education professional and currently the Director of the Innovati

      10/15/24 1:35:00 PM ET
      $GNS
      Services-Misc. Amusement & Recreation
      Consumer Discretionary

    $GNS
    $IINN
    SEC Filings

    See more
    • SEC Form 6-K filed by Genius Group Limited

      6-K - Genius Group Ltd (0001847806) (Filer)

      5/8/25 8:00:30 AM ET
      $GNS
      Services-Misc. Amusement & Recreation
      Consumer Discretionary
    • SEC Form 6-K filed by Inspira Technologies Oxy B.H.N. Ltd.

      6-K - Inspira Technologies OXY B.H.N. Ltd (0001837493) (Filer)

      5/7/25 9:15:16 AM ET
      $IINN
      Medical/Dental Instruments
      Health Care
    • SEC Form 6-K filed by Genius Group Limited

      6-K - Genius Group Ltd (0001847806) (Filer)

      5/1/25 9:15:17 AM ET
      $GNS
      Services-Misc. Amusement & Recreation
      Consumer Discretionary

    $GNS
    $IINN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Aegis Capital reiterated coverage on Inspira Technologies Oxy with a new price target

      Aegis Capital reiterated coverage of Inspira Technologies Oxy with a rating of Buy and set a new price target of $10.00 from $9.00 previously

      11/1/21 12:39:26 PM ET
      $IINN
      Medical/Dental Instruments
      Health Care
    • Aegis Capital initiated coverage on Inspira Technologies Oxy with a new price target

      Aegis Capital initiated coverage of Inspira Technologies Oxy with a rating of Buy and set a new price target of $9.00

      8/26/21 10:05:11 AM ET
      $IINN
      Medical/Dental Instruments
      Health Care

    $GNS
    $IINN
    Financials

    Live finance-specific insights

    See more
    • Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates

      Significant progress in HYLA blood sensor and INSPIRA ART core technologies RA'ANANA, Israel, March 11, 2025 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies, today announced its financial results for the full year ended December 31, 2024, and provided a corporate update. Dagi Ben-Noon, Chief Executive Officer of Inspira, commented: "2024 was a transformative year for Inspira, marked by significant technological advancements and a major regulatory milestone. We successfully obtained 510(k) clearance from the Food and Drug Administration ("FDA") for our INSPIRA™ ART100 system an

      3/11/25 8:30:00 AM ET
      $IINN
      Medical/Dental Instruments
      Health Care
    • Genius Group calls EGM to approve share buyback, cancels rights offering.

      SINGAPORE, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE:GNS) ("Genius Group" or the "Company"), a leading AI-powered, Bitcoin-first education group, announced today that its Board of Directors (the "Board") has called for an EGM for shareholders to authorize the Board to carry out a share buyback of up to 20% of the issued share capital of the Company, and to approve the creation of a new class of ordinary shares and preferred shares. In light of the Company's current share price below the exercise price of its previously announced rights offering, the Board has also voted to cancel the rights offering at this time. The Company will continue with its plan to increase its B

      2/12/25 8:00:00 AM ET
      $GNS
      Services-Misc. Amusement & Recreation
      Consumer Discretionary
    • Genius Group acquires Bitcoin Learning Platform, XD Academy

      SINGAPORE, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Genius Group Limited (NYSE:GNS) ("Genius Group" or the "Company"), a leading AI-powered, Bitcoin-first education group, today announced that it has acquired Bitcoin and Blockchain Learning Platform, XD Academy. XD Academy, originally launched as BitMEX Academy, the learning platform for cryptocurrency exchange, BitMEX. It was subsequently spun off as a separate company, led by its founder and CEO, Lawrence Linker. Genius Group has acquired XD Academy's learning platform and courses, which it is integrating into its Genius learning platform, including: "The Economics of Bitcoin" by Saifedean Ammous, the author of "The Bitcoin Standard", the be

      12/6/24 8:00:00 AM ET
      $GNS
      Services-Misc. Amusement & Recreation
      Consumer Discretionary